26 May 2026
Sun Pharma says it will not give margin guidance as the West Asia conflict is expected to increase logistics and shipping costs in coming quarters.
West Asia generates meaningful revenue for Sun Pharma.
Every Finvezto stock note on Sun Pharma, dated and newest first. Coverage spans pharma.
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.